217302-90-4

Basic information

• Product Name: 5-nitro-2-propylpyridine
• Synonyms: 5-nitro-2-propylpyridine
• CAS NO: 217302-90-4
• Molecular Weight: 166.18
• Mol File: 217302-90-4.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 5-nitro-2-propylpyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-nitro-2-propylpyridine(217302-90-4)
• EPA Substance Registry System: 5-nitro-2-propylpyridine(217302-90-4)

Safety Data

• Hazardous Substances Data: 217302-90-4(Hazardous Substances Data)

Upstream product

• 21203-68-9 2-methyl-5-nitropyridine 
• 4548-45-2 2-chloro-5-nitropyridine 
• 18995-13-6 Diethyl ethylsodiomalonate 
• 853915-77-2 2-<1,1-bis(ethoxycarbonyl)propyl>-5-nitropyridine 
• 7664-93-9 sulfuric acid 
• 14150-94-8 3,5-dinitro-1-methyl-2-pyridone 
• 107-87-9 2-Pentanone 
• 105-53-3 diethyl malonate 
• 60891-70-5 1,3-diethyl 2-(5-nitropyridin-2-yl)propanedioate 

Downstream Products

• 20609-24-9 6-propyl-pyridin-3-ol 
• 217302-93-7 5-benzyloxy-2-n-propylpyridine 
• 217302-95-9 6-benzyloxy-2-(4-benzyloxyphenyl)-1-ethylindolizine 
• 217302-97-1 dimethyl 7-benzyloxy-3-(4-benzyloxyphenyl)-4-ethylpyrrolo[2,1,5-cd]indolizine-1,2-dicarboxylate 
• 217302-98-2 7-benzyloxy-3-(4-benzyloxyphenyl)-4-ethylpyrrolo[2,1,5-cd]indolizine-1,2-dicarboxylic acid 
• 5457-27-2 trans-5-hydroxy-2-propylpiperidine 
• 217302-91-5 5-amino-2-propylpyridine 

Relevant articles and documents

Tailor-made synthesis of N,N,2,6-tetrasubstituted 4-nitroanilines by three-component ring transformation of dinitropyridone

The ring transformation of dinitropyridone afforded various kinds of 2,6-disubstituted-4-nitroanilines upon treatment with aliphatic ketones in the presence of ammonium acetate as a nitrogen source, wherein dinitropyridone behaved as the synthetic equival

Pyrrolo[2,1,5-cd]indolizine derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

The present invention relates to therapeutically active compounds of formula I a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in the prevention or treatment of estrogen related diseases or syndromes.